IP Library › Assignment 030032/0621
Patent Assignment
Reel/Frame 030032/0621

Assignment of Assignor's Interest

Recorded: 2013-03-18 Pages: 10
Assignors
SAHIN, UGUR
Executed: 2013-01-17
TURECI, OZLEM
Executed: 2013-01-21
KOSLOWSKI, MICHAEL
Executed: 2013-01-19
WALTER, KORDEN
Executed: 2013-01-17
KREUZBERG, MARIA
Executed: 2013-01-17
LUXEN, SYLVIA
Executed: 2013-01-17
Assignees
GANYMED PHARMACEUTICALS AG
FREILIGRATHSTRASSE 12, MAINZ, 55131, GERMANY
JOHANNES GUTENBERG-UNIVERSITAT MAINZ
SAARSTRASSE 21, MAINZ, 55122, GERMANY
Covered Property (1)
Cancer Therapy Using CLDN6 Target-Directed Antibodies in Vivo
Patent: 9,718,886 →
Application: 13/808,423 →
Publication: US 2013/0183305
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the First Assignee Data Previously Recorded at Reel: 030032 Frame: 0621. Assignor(S) Hereby Confirms the Assignment. Aug 10, 2016
From: SAHIN, UGUR; TURECI, OZLEM; KOSLOWSKI, MICHAEL; WALTER, KORDEN
To: GANYMED PHARMACEUTICALS AG; JOHANNES GUTENBERG-UNIVERSITAT MAINZ
Reel/Frame 039641/0343 →
Assignment of Assignor's Interest Apr 8, 2020
From: GANYMED PHARMACEUTICALS AG
To: GANYMED PHARMACEUTICALS GMBH
Reel/Frame 052340/0927 →